Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 9, 2008, Pages 1588-1596

  Yang, Qing Wu ^a   Li, Jing Cheng ^a   Lu, Feng Lin ^a   Ai Qing, Wen ^a   Xiang, Jing ^a   Zhang, Li Li ^a   Huang, Zhi Yu ^a   Wang, Jing Zhou ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute cerebral infarction; Inflammation; MyD88; Stroke; TLR4

Indexed keywords

CD14 ANTIGEN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWNSTREAM PROCESSING; EMBRYO; FEMALE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; KNOCKOUT MOUSE; MALE; MONOCYTE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; STROKE; TRANSIENT ISCHEMIC ATTACK; WILD TYPE;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 50249102689     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2008.50     Document Type: Article

References (35)

1. Akira S (2006) TLR signaling. Curr Top Microbiol Immunol 311:1-16
2. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ (2007) Reduced cerebral ischemia-reperfusion injury in toll-like receptor 4 deficient mice. Biochem Biophys Res Commun 353:509-14
3. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I (2007) Toll-like receptor 4 is involved in brain injury and inflammation after experimental stroke circulation. Circulation 115:1599-608
4. Frizzell JP (2005) Acute stroke: pathophysiology, diagnosis, and treatment. AACN Clin Issues 16:421-40
5. Garlichs CD, Kozina S, Fateh-Moghadam S, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeiber A, Yilmaz A, Ludwig J, Neundorfer B, Daniel WG (2003) Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 34:1412-8
6. Geng HL, Lu HQ, Zhang LZ, Zhang H, Zhou L, Wang H, Zhong RQ (2005) Increased expression of toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease. Clin Exp Immunol 143:269-73
7. Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, Singh I, Singh AK (2004) Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 76:519-27
8. Kim JB, Yu YM, Kim SW, Lee JK (2005) Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060:188-92
9. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735-40
10. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-86
11. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 100:8514-9
12. Lin YC, Chang YM, Yu JM, Yen JH, Chang JG, Hu CJ (2005) Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180:305-9
13. Longa EC, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
14. Lyden P, Brott T, Tilley B, Welch KMA, Mascha EJ, Levine S, Haley EC, Grotta J, The NINDS TPA Stroke Group (1994) Improved reliability of the NIH Stroke Scale using video training. Stroke 25:2220-6
15. Majid A, He YY, Gidday JM, Kaplan SS, Gonzales ER, Park TS, Fenstermacher JD, Wei L, Choi DW, Hsu CY (2000) Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains. Stroke 31:2707-14
16. Mergenthaler P, Dirnagl U, Meisel A (2004) Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 19:151-67
17. Methe H, Kim JO, Kofler S, Weis M, Nabauer M, Koglin J (2005) Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 111:2654-61
18. Michelsen KS, Doherty TM, Shah PK, Arditi M (2004) Role of toll-like receptors in atherosclerosis. Circ Res 95:e96-7
19. Miyake K (2004) Endotoxin recognition molecules MD-2 and toll-like receptor 4 as potential targets for therapeutic intervention of endotoxin shock. Curr Drug Targets Inflamm Allergy 3:291-7
20. Mogi M, Iwai M, Horiuchi M (2006) New paradigm for brain protection after stroke. Hypertension 47:642-9
21. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26:654-65
22. Ohashi K, Burkart V, Flohé S, Kolb H (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558-61
23. Oyama J, Blais C, Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Cirulation 109:784-9
24. Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J (2007) Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 49:93-102
25. Poltorak A, He X, Smimoval I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS siganaling in C3H/Hej and C57BL/10ScCr mice: mutation in TLR4 gene. Science 282:2085-8
26. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP (2007) Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA 104:13798-803
27. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-7
28. Triantafilou M, Triantafilou K (2004) Heat-shock protein 70 and heat-shock protein 90 associate with toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans 32:636-9
29. Tsan MF, Gao B (2004) Endogenous ligands of toll-like receptors. J Leukoc Biol 76:514-9
30. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR (2005) Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175:7661-8
31. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G, de Kleijn DP (2002) In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106:1985-90
32. Wang G, Siow YL (2000) Homocysteine stimulates nuclear factor-kappaB activity and monocyte chemoatt reactant protein 21 expression in vascular smooth muscle cells: a possible role for protein kinase C. Biochem J 352:817-826
33. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361-403
34. Yang QW, Zhu PF, Wang ZG, Jiang JX (2002) Toll-like receptor 4 medicates LPS-induced NF-κB activation in endothelial cells. Prog Biochem Biophy 29:407-11
35. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, Cheng G, Kupiec-Weglinski JW (2004) Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173:7115-9